RISK OBSERVATORY / Company Intelligence
ANNUAL DATA · BASE 2025 Sources ↗

FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

ABTSAbits Group Inc
Inspect →
ABUSArbutus Biopharma Corp
Inspect →
ABVCABVC BIOPHARMA, INC.
Inspect →
ABVEFAbove Food Ingredients Inc.
Inspect →
ABVXAbivax S.A.
Inspect →
ABXAbacus Global Management, Inc.
Inspect →
ABXXFAbaxx Technologies Inc.
Inspect →
ACAArcosa, Inc.
Inspect →
ACAAAverin Capital Acquisition Corp.
Inspect →
ACADACADIA PHARMACEUTICALS INC
Inspect →
ACATNP Life Sciences Health Industry Group Inc.
Inspect →
ACBAURORA CANNABIS INC
Inspect →

03 / FINANCIAL CHANGES

Paylocity Holding Corp PCTY

Services-Prepackaged Software · SIC 7372

Full analysis →
Latest financial filing listed10-Q · 2026-11-06 · Period ending: 2026-09-30A listed filing may be newer than the financial figures imported here. It does not mean the data have been processed.

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-06 · Retrieved: 2026-11-09

Compared with the same period of the prior year, ending 2025-09-30.

Revenue424.47

USD million

Change year over year: +45.61 · +12.0%
Net income57.64

USD million

Change year over year: +9.65
Operating cash flow79.69

USD million

Change year over year: -6.77
Total liabilities3,396.05

USD million

Change year over year: +263.40
Total assets4,545.64

USD million

Change year over year: +309.50

Liabilities / assets: 74.7% · Change: +0.8 percentage points

Open original filing ↗

Latest annual report

Period ending 2026-06-30

Filed: 2026-08-05 · Retrieved: 2026-11-09

Compared with the same period of the prior year, ending 2025-06-30.

Revenue1,651.36

USD million

Change year over year: +179.56 · +12.2%
Net income269.74

USD million

Change year over year: +42.61
Operating cash flow533.25

USD million

Change year over year: +115.03
Total liabilities3,662.94

USD million

Change year over year: +507.26
Total assets4,884.36

USD million

Change year over year: +494.93

Liabilities / assets: 75.0% · Change: +3.1 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

CompanyPeriod endingRevenue (USD million)Net marginOperating cash margin
MRDN ↗2025-12-31182.86-50.3%13.9%
KLTR ↗2025-12-31180.85-6.7%8.0%
SSNC ↗2025-12-316,272.2012.7%27.8%
QLYS ↗2025-12-31669.1329.6%46.2%
TTWO ↗2026-03-316,656.40-4.5%9.4%
AIFF ↗2025-12-311.14-1,741.0%-717.5%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

ABUS ↗

Arbutus Biopharma Corp

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

MRDN ↗

Meridian Holdings Inc./NV

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

KURA ↗

Kura Oncology, Inc.

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

IBIO ↗

iBio, Inc.

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

SNWV ↗

SANUWAVE Health, Inc.

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

BNGO ↗

Bionano Genomics, Inc.

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

GEVO ↗

Gevo, Inc.

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

AVNW ↗

AVIAT NETWORKS, INC.

Filed
2026-11-10
Period ending
2026-10-02
Latest standalone quarter

NCMI ↗

National CineMedia, Inc.

Filed
2026-11-10
Period ending
2026-10-01
Latest annual report

SBH ↗

Sally Beauty Holdings, Inc.

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

SNOA ↗

Sonoma Pharmaceuticals, Inc.

Filed
2026-11-10
Period ending
2026-09-30
Latest standalone quarter

PALI ↗

PALISADE BIO, INC.

Filed
2026-11-10
Period ending
2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →
Understand this in a few lines

For example

General explanation, not an assessment of your individual situation